Heparanase 1 Monoclonal Monoclonal Antibody [HP3/17] (CPAB0124)
- SKU:
- CPAB0124
- Product Type:
- Antibody
- Antibody Type:
- Monoclonal Antibody
- Reactivity:
- Human
- Host Species:
- Mouse
- Isotype:
- IgG2B?
- Applications:
- WB
- IHC
Description
Heparanase 1 Monoclonal Monoclonal Antibody [HP3/17] (CPAB0124)
The Heparanase-1 Monoclonal Antibody (Clone HP3-17) is specifically designed for research involving heparanase-1, an enzyme that plays a key role in remodeling the extracellular matrix and promoting tumor metastasis. This antibody, generated using hybridoma technology, is highly specific and reacts with human samples, making it a valuable tool for studying the expression and function of heparanase-1 in various biological samples.Heparanase-1 is known for its involvement in cancer progression, as it facilitates tumor cell invasion and metastasis by degrading heparan sulfate proteoglycans in the extracellular matrix. By targeting heparanase-1 with this monoclonal antibody, researchers can gain insights into the mechanisms driving tumor metastasis and potentially identify novel therapeutic targets for cancer treatment.
With its high specificity and reliability in immunohistochemistry and other applications, the Heparanase-1 Monoclonal Antibody (Clone HP3-17) is a valuable asset for studies in cancer biology, tumor microenvironment, and metastasis research. By enabling the detection and analysis of heparanase-1 expression, this antibody opens up new possibilities for understanding the role of this enzyme in cancer progression and developing targeted therapies to inhibit its activity.
Product Name: | Heparanase 1 Clone HP3/17 |
Product Sku: | CPAB0124 |
Size: | 50μg |
Host Species: | Mouse |
Immunogen: | |
Clone: | |
Reactivity: | Human |
Applications: | Western Blot, Immunohistochemistry |
Purification Method: | |
Isotype: | IgG2B? |
Background: | Heparanase is an endo-?-D-glucuronidase, which degrades heparan sulfate side chains of heparan sulfate proteoglycans (HSPGs) in the extracellular matrix. Heparanase plays an important role in ECM degradation, facilitating the migration and extravasation of tumor cells and inflammatory leukocytes (1,2,3). Upon degradation, heparanase releases growth factors and cytokines that stimulate cell proliferation and chemotaxis (4,5). Heparanase is a heterodimer comprised of a 50 kDa subunit harboring the active site and a 8 kDa subunit. It is produced as a latent 65 kDa precursor and proteolytically processed to its active form (1,6). Heparanase is highly expressed in myeloid leukocytes (i.e. neutrophils) in platelets and in human placenta. Human heparanase was found to be upregulated in various types of primary tumors, correlating in some cases with increased tumor invasiveness and vascularity and with poor prospective survival (7,8). |
Synonyms: | |
Storage Buffer: |